Evidence map›Paper›PMID 40445285›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

siRNA Silencing of Adipogenic Gene in ASCs.

Pontsho Moela

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pontsho MoelaDivision of Genetics, Department of Biochemistry, Genetics, and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria, South Africa. pontsho.moela@up.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common technique used in silencing gene expression adopts a naturally occurring cellular process called RNA interference (RNAi), which uses a double-stranded RNA molecule to silence homologous endogenous genes by degrading their cognate mRNA transcripts. The presence of long double-stranded RNA molecules triggers this process, which ensues by first shortening the lengthy transcripts enzymatically followed by their incorporation into the RISC complex thus allowing it to find and degrade complementary mRNA sequences. In an in vitro setting, short interfering oligonucleotides are commercially synthesized and commonly transfected into mammalian cells through lipofection. This current chapter illustrates the silencing of PPARγ gene using RNAi in adherent mammalian cells.

Indexed as

AdipocytesAdipogenesisAdipose TissueGene SilencingPPAR gammaRNA InterferenceRNA, Small InterferingHumansTransfectionPPAR gammaRNA, Small InterferingAdipogenesisLipofectionPPARγRNA interferencesiRNA

Identifiers

PMID40445285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.